Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Pediatric Open-Label Extension Study

ClinicalTrials.gov ID: NCT01914393

Public ClinicalTrials.gov record NCT01914393. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects

Study identification

NCT ID
NCT01914393
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
702 participants

Conditions and interventions

Interventions

  • Lurasidone 20, 40, 60, 80 mg, flexibly dosed Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2013
Primary completion
Oct 16, 2018
Completion
Oct 16, 2018
Last update posted
Dec 18, 2019

2013 – 2018

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303
Diligent Clinical Trials, Inc Downey California 90241
University of California San Francisco Medical Center San Francisco California 94143
Neuropsychiatric Research Center of Orange County Santa Ana California 92701
Sarkis Clinical Trials - Parent Gainesville Florida 32607
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
APG Research, LLC Orlando Florida 32803
Medical Research Group of Central Florida Sanford Florida 32771
University of South Florida St. Petersburg Florida 33701
University of South Florida Rothman Center of Neuropychiatry Tampa Florida 33613
Atlanta Center for Medical Research Atlanta Georgia 30308
Attalla Consultants, LLC Smyrna Georgia 30080
Psychiatric Associates Overland Park Kansas 66211
University Of Kentucky Lexington Kentucky 40509
Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340 Lake Charles Louisiana 70601
Kennedy Krieger Institute Baltimore Maryland 21205
Neurobehavioral medicine Group, LLC Bloomfield Hills Michigan 48302
St. Charles Psychiatric Associates Saint Charles Missouri 63301
Jersey Shore University Medical Center Neptune City New Jersey 07753
North Shore/Long Island Jewish PRIME Glen Oaks New York 11004
Dr. Jeanette Cueva Mount Kisco New York 10549
Montefiore Medical Center PRIME New York New York 10467
Finger Lakes Clinical Research Rochester New York 10618
Richmond Behavioral Associates Staten Island New York 10312
University of Cincinnati Medical Center Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
The Ohio State University Nisonger Center Columbus Ohio 43210
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Pillar Clinical Research, LLC Dallas Texas 75243
Family Psychiatry of The Woodlands, P.A. The Woodlands Texas 77381
Ericksen Research & Development, LLC Clinton Utah 84015
University of Virginia Charlottesville Virginia 22903
Neuroscience, Inc. Herndon Virginia 20170
Clinical Research Partners, LLC Petersburg Virginia 23805
Carilion Clinic Roanoke Virginia 24014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01914393, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01914393 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →